Cytokines in Autoimmune Disorders

References

• Allison J., Malcolm L., Chosich N., Miller J. F.A.P. Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of IL-2 in islet β cells. Eur. J. Immunol. 1992; 22: 1115–21
   PubMedGoogle Scholar
• Arend W. P. Interleukin-1 receptor antagonist. Adv. Immunol. 1993; 54: 167–227
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Morling N., Fomsgaard A., Svenson M., Jakobsen B., Odum N., Svejgaard A. Association between HLA-DR2 and productio of tumour necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 1988; 28: 599–606
   PubMed Web of Science ®Google Scholar
• Bottazzo G. F., Pujol-Borrell R., Hanafusa T., Feldmann M. Hypothesis: Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet 1983; ii: 1115–9
   Google Scholar
• Brennan F. M., Chantry D., Jackson A., Maini R., Feldmann M. Inhibitory effect of TNF α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989; 2: 244–7
   PubMed Web of Science ®Google Scholar
• Brennan F. M., Feldmann M. F. Cytokines in Autoimmunity. R.G. Landes, Austin, Texas 1996
   Google Scholar
• Bresnihan B., Lookbaugh J., Witt K., Musikic P. Treatment with recombinant human interleukin-1 receptor antagonist (rhIL-1ra) in rheumatoid arthritis (RA): results of a randomized double-blind, placebo-controlled multicenter trial. Arthritis Rheum. 1996; 39: S282
   Google Scholar
• Bresnihan B., Mulherin D., FitzGerald O. Synovial pathology and articular erosion in rheumatoid arthritis. Rheumatology in Europe 1995; 24(S)158–60
   Google Scholar
• Buchan G., Barrett K., Turner M., Chantry D., Maini R. N., Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin. Exp. Immunol. 1988; 73: 449–55
   PubMed Web of Science ®Google Scholar
• Burman P., Totterman T. H., Oberg K., Anders Karlsson F. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J. Clin. Endocrinol. Metab. 1986; 63: 1086–90
   PubMed Web of Science ®Google Scholar
• Butler D. M., Maini R. N., Feldmann M., Brennan F. M. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti-TNFα antibody with the IL-1 receptor antagonist. Eur. Cytokine. Netw. 1995; 6: 225–30
   PubMed Web of Science ®Google Scholar
• Cope A. P., Aderka D., Doherty M., Engelmann H., Gibbons D., Jones A. C., Brennan F. M., Maini R. N., Wallach D., Feldmann M. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum. 1992; 35: 1160–9
   PubMed Web of Science ®Google Scholar
• Cutulo M., Kirkham B., Bologna C., Sony J., Scott D., Brooks P., Forre O., Jain R., Markensen J., Seebold J., Sturrock R., Veys E., Edwards J., Zaug M., Durrwell L., Bisschops C., Milnarik P., Baudin Mond van der Auwera P. Loading/maintenance doses approach to neutralization of TNF by lenercept in patients with rheumatoid arthritis treated for 3 months: results of a double blind placebo controlled phase II trial. Arthritis Rheum. 1996; 39(Suppl. 9)S243
   Google Scholar
• Elliott M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H., Woody J. N. Randomised double blind comparison of a chimaeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994a; 344: 1105–10
   PubMed Web of Science ®Google Scholar
• Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Bijl H., Woody J. N. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 1994b; 344: 1125–7
   PubMed Web of Science ®Google Scholar
• Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Katsikis P., Brennan F. M., Walker J., Bijl H., Ghrayeb J., Woody J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNFα. Arthritis Rheum. 1993; 36: 1681–90
   PubMed Web of Science ®Google Scholar
• Fava R., Olsen N., Keski-Oja J., Moses H., Pincus T. Active and latent forms of transforming growth factor β activity in synovial effusions. J. Exp. Med. 1989; 169: 291–6
   PubMed Web of Science ®Google Scholar
• Feldmann M., Brennan F. M., Maini R. N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996; 14: 397–440
   PubMed Web of Science ®Google Scholar
• Fong Y., Tracey K. J., Moldawer L. L., Hesse D. G., Manogue K. B., Kenney J. S., Lee A. T., Kuo G. C., Allison A. C., Lowry S. F., Cerami A. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 1989; 170: 1627–33
   PubMed Web of Science ®Google Scholar
• Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987; 30: 1205–13
   PubMed Web of Science ®Google Scholar
• Gu D.-L., Wogensen L., Calcutt N. A., Xia C.-Y., Zhu S.-M., Merlie J. P., Fox H. S., Lindstrom J., Powell H. C., Sarvetnick N. Myastenia gravis-like syndrome Induced by expression of interferon-gamma in the neuromuscular junction. Journal of Experimental Medicine 1995; 181: 547–57
   Google Scholar
• Hanafusa T., Pujol-Borrell R., Chiovato L., Russell R. C.G., Doniach D., Bottazzo G. F. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983; ii: 1111–5
   Google Scholar
• Haworth C., Brennan F. M., Chantry D., Turner M., Maini R. N., Feldmann M. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur. J. Immunol. 1991; 21: 2575–9
   PubMed Web of Science ®Google Scholar
• Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 1990; 87: 1233–7
   PubMed Web of Science ®Google Scholar
• Jacob C. O., McDevitt H. O. Tumour necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis. Nature 1988; 331: 356–8
   PubMed Web of Science ®Google Scholar
• Jacob C O, van der Meide P. H., McDevitt H. O. In vivo, treatment of (NZB NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med. 1987; 166: 798–803
   PubMed Web of Science ®Google Scholar
• Janossy G., Panayai G., Duke O., Bofill M., Poulter L. W., Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 1981; ii: 839–42
   Google Scholar
• Katsikis P., Chu C. Q., Brennan F. M., Maini R. N., Feldmann M. Immunoregulatory role of interleukin 10 (IL-10) in rheumatoid arthritis. J. Exp. Med. 1994; 179: 1517–27
   PubMed Web of Science ®Google Scholar
• Klareskog L., Forsum U., Scheynius A., Kabelitz D., Wigzell H. Evidence in support of a self perpetuating HLA-DR dependent delayed type cell reaction in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 1982; 72: 3632–6
   Google Scholar
• Maini R. N., Elliott M. J., Charles P. J., Feldmann M. Immunological intervention reveals reciprocal roles for TNFα and IL-10 in rheumatoid arthritis and SLE. Springer Semin Immunopathol. 1994; 16: 327–36
   PubMedGoogle Scholar
• McDowell T. L., Symons J. A., Ploski R., Forre O., Duff G. W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum. 1995; 38: 221–8
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Coffman R. L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–73
   PubMed Web of Science ®Google Scholar
• Oppenheim J. J., Saklatvala J. Cytokines and their receptors. Clinical applications of cytokines: role in pathogenesis, diagnosis and therapy, J. J. Oppenheim, J. L. Rossio, A. J.H. Gearing. Oxford University Press, Oxford 1993; 3–15
   Google Scholar
• Sarvetnick N., Shizuru J., Liggitt D., Martin L., McLntyre B., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 1990; 346: 844–7
   PubMed Web of Science ®Google Scholar
• Saxne T., Palladino M. A., Jr., Heinegard D., Talal N., Wollheim F. A. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 1988; 31: 1041–5
   PubMed Web of Science ®Google Scholar
• Silman A. J., MacGregor A. J., Thomson W., Holligan S., Carthy D., Farhan A., Oilier W. E.R. Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Br. J. Rheumatol. 1993; 32: 903–7
   PubMedGoogle Scholar
• Stewart T. A., Hultgren B., Huagn X., Pitts-Meek S., Hully J., McLachlan N. J. Induction of type-1 diabetes by interferon-a in transgenic mice. Science 1993; 260: 1942–7
   PubMed Web of Science ®Google Scholar
• Williams R. O., Mason L. J., Feldmann M., Maini R. N. Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 1994; 91: 2762–6
   PubMed Web of Science ®Google Scholar
• Wilson A. G., Gordon C., di Giovine F. S., de Vries N., van de Putte L. B.A., Emery P., Duff G. W. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur. J. Immunol. 1994; 24: 191–5
   PubMed Web of Science ®Google Scholar
• Wood N. C., Dickens E., Symons J. A., Duff G. W. In situ, hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. Clin. Immunol. Immunopathol. 1992; 62: 295–300
   PubMedGoogle Scholar
• Yssel H., de Waal Malefyt R., Roncarolo M. G., Abrams J. S., Lahesmaa R., Spits H., de Vries J. E. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J. Immunol. 1992; 149: 2378–84
   PubMed Web of Science ®Google Scholar